Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 57,476 | 51,500 | 46,617 | 44,860 | 58,234 |
| Cost of Goods | 23,824 | 22,495 | 21,181 | 21,847 | 25,186 |
| Gross Profit | 33,652 | 29,005 | 25,436 | 23,013 | 33,048 |
| Operating Expenses | 31,490 | 33,748 | 34,144 | 34,594 | 33,370 |
| Operating Income | 2,986 | -4,248 | -8,527 | -10,734 | -136 |
| Interest Expense | -5,933 | 119 | 134 | 441 | 394 |
| Other Income | 1,403 | 4,524 | 1,475 | 2,182 | 4,641 |
| Pre-tax Income | 10,322 | 157 | -7,186 | -8,993 | 4,111 |
| Income Tax | 680 | -784 | 3,248 | -2,824 | -1,392 |
| Net Income Continuous | 9,642 | 941 | -10,434 | -6,169 | 5,503 |
| Net Income | $9,642 | $941 | $-10,434 | $-6,169 | $5,503 |
| EPS Basic Total Ops | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
| EPS Basic Continuous Ops | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
| EPS Diluted Total Ops | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
| EPS Diluted Continuous Ops | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.01 | -0.08 | N/A | N/A |
| EBITDA(a) | $5,727 | $-1,439 | $-6,047 | $-8,274 | $2,289 |